December 20, 2016
Biogen names Michel Vounatsos new CEO
Biogen’s Board of Directors has appointed Michel Vounatsos as Chief Executive Officer and member of the Board of Directors, effective…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
December 20, 2016
Silence Therapeutics settles with Quark Pharmaceuticals
Silence Therapeutics and Quark Pharmaceuticals have settled in the arbitration regarding a milestone payment, as Silence is to receive a…
December 20, 2016
Novartis, Conatus in borad deal to make treatments for liver diseases
Novartis and Conatus Pharmaceuticals have signed a multipurpose deal which will help the two drug makers to make liver-disease treatment,…
December 20, 2016
Provexis continues to study food supplement Frutiflow with University of Oslo
Provexis has continued working with the University of Oslo undertaking further research into the relationship between Fruitflow – aheart-health functional…
December 19, 2016
GSK/Ivannova study Relvar/Breo once-daily cobination
GlaxoSmithKline and Innoviva have started a phase III study to compare certain triple combination asthma therapy with a double combination…
December 19, 2016
Vertex announces German reimbursement agreement for its cystic fibrosis drug
Vertex Pharmaceuticals Incorporated has reached a pricing and reimbursement agreement for Orkambi (lumacaftor/ivacaftor) with the German Federal Association of the…
December 19, 2016
Hungarian Richter withdraws biosimilar drug marketing authorisation application from EMA
Gedeon Richter Plc., a Hungarian drugmaker has withdrawn its Marketing Authorization Application (MAA) from the European Medicines Agency (EMA) for…
December 19, 2016
Adocia/Lilly successfully complete insulin pump study
Adocia and Eli Lilly have completed an insulin pump study under the Adocia-Lilly partnership evaluating BioChaperone Lispro, an ultra-rapid formulation…
December 19, 2016
Innate Pharma picks AstraZeneca’s oncology specialist Mondher Mahjoubi
Innate Pharma has announced key leadership team and Board changes which will take effect on December 30th, 2016.
December 19, 2016
Veloxis increases capital by 1,5M new shares
Danish pharmaceutical company Veloxis Pharmaceuticals A/S, has increased its capital by 1,500,000 new shares. The company said on Monday that…